Aion Therapeutic Inc. completed the acquisition of Toppen Health Inc.
The completion of the Proposed Acquisition is subject to the successful completion of the Company?s due diligence review of Toppen, the approval of the Canadian Securities Exchange and other customary closing conditions. The completion of the Proposed Acquisition is currently expected to occur by the end of 2023. William Morris of Mawicke & Goisman acted as legal advisor to Toppen Health. Alexander Lalka of Miller Thomson LLP acted as legal advisor to Aion Therapeutic Inc.
Aion Therapeutic Inc. (CNSX:AION) completed the acquisition of Toppen Health Inc. on December 15, 2023.